Product Details

VERMOXI-K is a sterile ophthalmic solution. It combines an antibiotic and an anti-inflammatory agent for combined infection and pain control. As a result, ophthalmologists commonly prescribe it for post-surgical and infective-inflammatory eye conditions.

The eye drops combine:

• Moxifloxacin – This fourth-generation fluoroquinolone antibiotic inhibits bacterial DNA gyrase and topoisomerase IV. Consequently, it stops bacterial DNA replication and clears susceptible ocular infections.
• Ketorolac – This NSAID inhibits cyclooxygenase (COX-1 and COX-2) enzymes in ocular tissue. Therefore, it reduces prostaglandin synthesis, easing pain and inflammation without steroid-related risks.

Together, these two agents treat infection and pain simultaneously. So, VERMOXI-K suits post-operative eye care, where both antibacterial coverage and steroid-free anti-inflammatory relief are needed. Because of this, ophthalmologists commonly use it following ocular surgeries such as cataract procedures.

Key Features

• The formula meets sterility standards for safe ocular use
• Dual-action formula combines antibacterial and steroid-free anti-inflammatory effects
• The combination suits post-surgical eye care and infective-inflammatory conditions
• A compact 5ml dropper bottle allows accurate, controlled dosing
• The formula suits hospital, clinic, and retail pharmacy distribution
• A clear “use within one month of opening” note supports safe patient use